Skip to content

ENDRA LIFE SCIENCES INC.: 10-Q filed 2021-11-15

What ENDRA LIFE SCIENCES INC. reported in its quarterly report filed 2021-11-15 (fiscal Q3 2021): 35 published measures, 93 facts as tagged in accession 0001654954-21-012249.

This filing

Form
10-Q (quarterly report)
Filed
2021-11-15
Fiscal period
fiscal Q3 2021
Accession
0001654954-21-012249 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ENDRA LIFE SCIENCES INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2021-09-3015,314,206USD
At 2020-12-318,764,976USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2021-09-302,158,140USD
At 2020-12-311,595,655USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2021-09-3013,156,066USD
At 2021-06-3014,989,898USD
At 2020-12-317,169,321USD
At 2020-09-303,334,982USD
At 2020-06-30976,880USD
At 2019-12-314,760,670USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-2,658,242USD92
2021-01-01 to 2021-09-30-8,126,622USD273
2020-07-01 to 2020-09-30-3,258,071USD92
2020-01-01 to 2020-09-30-9,474,740USD274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-8,469,653USD273
2020-01-01 to 2020-09-30-8,673,489USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2021-01-01 to 2021-09-3045,000USD273
2020-01-01 to 2020-09-3010,483USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2021-01-01 to 2021-09-3013,080,526USD273
2020-01-01 to 2020-09-306,303,058USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-45,000USD273
2020-01-01 to 2020-09-30-10,483USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2021-09-30-65,586,182USD
At 2020-12-31-57,338,489USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2021-07-01 to 2021-09-300USD92
2021-01-01 to 2021-09-300USD273
2020-07-01 to 2020-09-300USD92
2020-01-01 to 2020-09-300USD274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2021-09-30162,265USD
At 2020-12-31212,242USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2021-01-01 to 2021-09-301,032,835USD273
2020-01-01 to 2020-09-301,559,232USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-2,650,735USD92
2021-01-01 to 2021-09-30-8,426,764USD273
2020-07-01 to 2020-09-30-3,255,450USD92
2020-01-01 to 2020-09-30-9,247,575USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2021-09-3014,470,133USD
At 2020-12-318,207,736USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2021-09-301,576,826USD
At 2020-12-31986,663USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2021-09-30747,762USD
At 2020-12-31402,910USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2021-07-01 to 2021-09-302,650,735USD92
2021-01-01 to 2021-09-308,426,764USD273
2020-07-01 to 2020-09-303,255,450USD92
2020-01-01 to 2020-09-309,247,575USD274

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2021-09-301,499,743USD
At 2020-12-31589,620USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2021-07-01 to 2021-09-301,173,319USD92
2021-01-01 to 2021-09-304,059,730USD273
2020-07-01 to 2020-09-301,769,339USD92
2020-01-01 to 2020-09-304,774,534USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2021-09-3042,165,726shares
At 2020-12-3134,049,704shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2021-09-3078,695,367USD
At 2020-12-3164,493,611USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2021-09-30675,822USD
At 2020-12-31339,012USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2021-09-30680,526USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2021-09-30680,845USD
At 2020-12-31585,867USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2021-09-305,986USD
At 2020-12-315,986USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-2,658,242USD92
2021-01-01 to 2021-09-30-8,126,622USD273
2020-07-01 to 2020-09-30-3,258,071USD92
2020-01-01 to 2020-09-30-9,474,740USD274

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-2,658,242USD92
2021-01-01 to 2021-09-30-8,247,693USD273
2020-07-01 to 2020-09-30-3,653,622USD92
2020-01-01 to 2020-09-30-9,870,291USD274

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2021-07-01 to 2021-09-301,201,851USD92
2021-01-01 to 2021-09-303,673,771USD273
2020-07-01 to 2020-09-301,346,360USD92
2020-01-01 to 2020-09-304,083,572USD274

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2021-01-01 to 2021-09-3094,977USD273
2020-04-01 to 2020-09-3045,114USD183

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2021-01-01 to 2021-09-3094,977USD273
2020-01-01 to 2020-09-3045,114USD274

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-7,507USD92
2021-01-01 to 2021-09-30-8,458USD273
2020-07-01 to 2020-09-30-2,621USD92
2020-01-01 to 2020-09-305,261USD274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-7,507USD92
2021-01-01 to 2021-09-30300,142USD273
2020-07-01 to 2020-09-30-2,621USD92
2020-01-01 to 2020-09-30-227,165USD274

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2021-01-01 to 2021-09-3040,887USD273
2020-01-01 to 2020-09-301,920USD274

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2021-01-01 to 2021-09-3010,294,899USD273
2020-01-01 to 2020-09-301,321,890USD274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-910,123USD273
2020-01-01 to 2020-09-30-209,766USD274

Inspect the source

Entity
ENDRA LIFE SCIENCES INC. / CIK 0001681682
Captured
2026-09-21T17:25:00.766Z
SEC response SHA-256
b2e333c22e503323f4789aca42dd3c9e6c3f90e7235cedf651b7302d68bfca7f

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001681682.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))